Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples